Tuesday, November 25, 2014

Isis Pharmaceuticals announces initiation of ISIS-SMN Rx Phase 3 study in children with SMA

›
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced  the initiation of a pivotal Phase 3 study evaluating ISIS-SMN Rx  in approximately 120 ...

University of Leeds researchers make new synthetic anti-cancer molecule

›
Researchers at the University of Leeds have made a new synthetic anti-cancer molecule that targets two key mechanisms in the spread of mal...
Monday, November 24, 2014

New drug combination shows promise as effective, safe treatment for rheumatoid arthritis

›
A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medi...
4 comments:
Friday, November 21, 2014

Sulindac drug can protect against oxidative damage due to AMD

›
In continuation of my update on Sulindac Scientists at Florida Atlantic University's Charles E. Schmidt College of Science, as wel...

FDA Approves Olysio (simeprevir) in Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C Infection

›
In continuation of my update on sofosbuvir Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food ...
Thursday, November 20, 2014

New treatment regimen for hepatitis C in transplant patients produces promising results

›
The investigational three-drug regimen, which produced hepatitis C cure rates of 97 percent, is an oral interferon-free therapy. Previou...
Wednesday, November 19, 2014

Study reports anti-cancer activity in mice treated with experimental drug TAK-733

›
Study reports anti-cancer activity in mice treated with experimental drug TAK-733 TAK-733 is a potent and selective MEK allosteric sit...
Tuesday, November 18, 2014

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

›
In continuation of my update on  Eribulin Eribulin (trade name: Halaven) is approved for women with locally advanced or metastatic br...
Monday, November 17, 2014

FDA Approves Dual-Chamber Syringe for Abilify Maintena (aripiprazole) for Schizophrenia

›
In continuation of my update on  aripiprazole We know that,  Aripiprazole  ( brand names:   Abilify ,   Aripiprex ) is a   atypical ...
Friday, November 14, 2014

FDA Approves Ofev (nintedanib) for Idiopathic Pulmonary Fibrosis

›
In continuation of update on  nintedanib The U.S. Food and Drug Administration today approved  Ofev  (nintedanib) for the treatment of...
Thursday, November 13, 2014

FDA Approves Revised Indication for Ozurdex for the Treatment of Diabetic Macular Edema

›
In continuation of my update on  dexamethasone Allergan, Inc., announced today that the U.S. Food and Drug Administration (FDA) h...
Wednesday, November 12, 2014

FDA Approves Esbriet (pirfenidone) for Idiopathic Pulmonary Fibrosis

›
Pirfenidone   is a drug developed by several companies worldwide, including InterMune Inc. (now part of Roche), Shionogi Ltd., and ...
Tuesday, November 11, 2014

FDA Approves Ofev (nintedanib) for Idiopathic Pulmonary Fibrosis

›
In continuation of update on  nintedanib The U.S. Food and Drug Administration today approved  Ofev  (nintedanib) for the treatmen...
Monday, November 10, 2014

An apple a day could keep obesity away

›
Sientists at Washington State University have concluded that non digestible compounds in apples -- specifically, Granny Smith apples  ma...

Researchers identify compounds that could lead to discovery of new drugs for African sleeping sickness

›
In early drug discovery, you need a starting point, says North­eastern Uni­ver­sity asso­ciate pro­fessor of chem­istry and chemical biolo...